Literature DB >> 29756176

Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?

Satish Kumar Bedada1, Prasad Neerati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29756176     DOI： 10.1007/s00228-018-2481-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  20 in total

1.  Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers.

Authors:  Satish Kumar Bedada; Prasad Neerati
Journal:  Phytother Res       Date:  2017-11-23       Impact factor: 5.878

2.  Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.

Authors:  J C Gorski; D R Jones; S A Wrighton; S D Hall
Journal:  Xenobiotica       Date:  1997-03       Impact factor: 1.908

3.  Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation.

Authors:  H Yamazaki; Z Guo; F P Guengerich
Journal:  Drug Metab Dispos       Date:  1995-03       Impact factor: 3.922

4.  Resveratrol Pretreatment Affects CYP2E1 Activity of Chlorzoxazone in Healthy Human Volunteers.

Authors:  Satish Kumar Bedada; Prasad Neerati
Journal:  Phytother Res       Date:  2015-12-17       Impact factor: 5.878

5.  The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone.

Authors:  G D Loizou; J Cocker
Journal:  Hum Exp Toxicol       Date:  2001-07       Impact factor: 2.903

6.  Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.

Authors:  D Lucas; R Ferrara; E Gonzalez; P Bodenez; A Albores; M Manno; F Berthou
Journal:  Pharmacogenetics       Date:  1999-06

7.  Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.

Authors:  S Ono; T Hatanaka; H Hotta; M Tsutsui; T Satoh; F J Gonzalez
Journal:  Pharmacogenetics       Date:  1995-06

8.  Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers.

Authors:  K Rajnarayana; A Venkatesham; Devarakonda R Krishna
Journal:  Drug Metabol Drug Interact       Date:  2007

9.  Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans.

Authors:  Sarah Egert; Siegfried Wolffram; Anja Bosy-Westphal; Christine Boesch-Saadatmandi; Anika Eva Wagner; Jan Frank; Gerald Rimbach; Manfred James Mueller
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

10.  Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.

Authors:  E D Kharasch; K E Thummel; J Mhyre; J H Lillibridge
Journal:  Clin Pharmacol Ther       Date:  1993-06       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.